| CTRI Number |
CTRI/2025/01/079769 [Registered on: 29/01/2025] Trial Registered Prospectively |
| Last Modified On: |
20/11/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Homeopathy |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Role of murphy repertory in the management of chronic urticaria |
|
Scientific Title of Study
|
Utility of homoeopathic medical repertory by Robin murphy in the management of chronic Urticaria assessed by urticaria activity score |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DR ARPITABEN RAJNIKANTBHAI PATEL |
| Designation |
PG SCHOLAR |
| Affiliation |
SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE |
| Address |
DEPARTMENT OF MEDICINE ROOM NO 6 GROUND FLOOR SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE PUSHPANJALI BUILDING NEAR DISTRICT SESSION COURT MEHSANA
Mahesana
GUJARAT
384001
India |
| Phone |
8401766070 |
| Fax |
|
| Email |
arpita53201@gmail.com |
|
Details of Contact Person
Scientific Query
|
| Name |
DR GAURANG CHHAYA |
| Designation |
PROFESSOR |
| Affiliation |
SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE |
| Address |
DEPARTMENT OF HOMOEOPATHIC REPERTORY AND CASE TAKING ROOM NO 14 FIRST FLOOR SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE PUSHPANJALI BUILDING NEAR DISTRICT SESSION COURT MEHSANA
Mahesana
GUJARAT
384001
India |
| Phone |
9979953933 |
| Fax |
|
| Email |
chhayagaurang62@gmail.com |
|
Details of Contact Person
Public Query
|
| Name |
DR ARPITABEN RAJNIKANTBHAI PATEL |
| Designation |
PG SCHOLAR |
| Affiliation |
SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE |
| Address |
DEPARTMENT OF MEDICINE ROOM NO 6 GROUND FLOOR SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE PUSHPANJALI BUILDING NEAR DISTRICT SESSION COURT MEHSANA
Mahesana
GUJARAT
384001
India |
| Phone |
8401766070 |
| Fax |
|
| Email |
arpita53201@gmail.com |
|
|
Source of Monetary or Material Support
|
| SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLAGE AND RESEARCH INSTITUTE PUSHPANJALI BUILDING NEAR DISTRICT SESSION COURT MEHSANA GUJARAT 384001 |
|
|
Primary Sponsor
|
| Name |
DR ARPITABEN RAJNIKANTBHAI PATEL |
| Address |
DEPARTMENT OF MEDICINE ROOM NO 6 GROUND FLOOR SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE PUSHPANJALI BUILDING NEAR DISTRICT SESSION COURT MEHSANA GUJARAT 384001 |
| Type of Sponsor |
Other [SELF] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR ARPITABEN RAJNIKANTBHAI PATEL |
SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESEARCH INSTITUTE |
DEPARTMENT OF MEDICINE ROOM NO 6 PUSHPANJALI BUILDING NEAR DISTRICT SESSION COURT MEHSANA GUJARAT 384001
Mahesana
GUJARAT |
8401766070
arpita53201@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| SMT A J SAVLA HOMOEOPATHIC MEDICAL COLLEGE AND RESERCH INSTITUTE INSTITUTIONAL ETHICAL COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: L508||Other urticaria, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
HOMOEOPATHIC MEDICINE |
POTENCY VERIOUS
DOSES AS PER NEED OF CASE
FREQUENCY AS PER NEED OF CASE
ROTE OF ADMINISTRATION ORAL
DURATION OF 8 MONTH AS PER NEED OF CASE
|
| Comparator Agent |
NIL |
NIL |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
40.00 Year(s) |
| Gender |
Both |
| Details |
Age group people from 20 to 40 years age group
Gender Male and Female
Case presenting with symptoms of chronic urticaria
Patient will be selected on the basis of clinically diagnosed characteristics of erythema and itchy lesions which is subside within 24 hour
Patients who gave voluntary consent and be able to fill the Urticaria Activity Score to be included in the study
Urticaria Activity Score over 1 week cases range between 7 to 27 include mild and moderate urticaria according Urticaria Activity Score
|
|
| ExclusionCriteria |
| Details |
Pregnant women and lactating women were not included in the study
Patient having other co morbid conditions associated with chronic urticaria such as thyroid disease inflammatory disease DM malignancy
Vasculitic urticaria angioedema with no urticaria anaphylaxia
Patient taking any mode of treatment like allopathic homoeopathic ayurvedic for urticaria
|
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Participant Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| URTICARIA ACTIVITY SCORE TO ASSESS REDUCTION IN URTICARIA SYMPTOMS |
SCORE WILL BE ASSESSED AT BASELINE AND EVERYMONTH OF TREATMENT AND AS PER REQUIREMENT OF CASES |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| NIL |
NIL |
|
|
Target Sample Size
|
Total Sample Size="40"
Sample Size from India="40"
Final Enrollment numbers achieved (Total)= "40"
Final Enrollment numbers achieved (India)="40" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
10/02/2025 |
| Date of Study Completion (India) |
10/10/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
10/10/2025 |
|
Estimated Duration of Trial
|
Years="1"
Months="6"
Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Completed |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
THIS STUDY IS A PROSPECTIVE STUDY PRE TEST POST TEST ONE GROUP EXPERIMENTAL STUDY TO ASSESS THE UTILITY OF HOMOEOPATHY MEDICAL REPERTORY BY ROBIN MURPHY FOR 8 MONTHS IN 40 PARTICIPANTS WITH CHRONIC URTICARIA THAT WILL BE CONDUCTED AS PER INCLUSION AND EXCLUSION CRITERIA FROM OUT PATIENT DEPARTMENT AND THE OUTCOMES MEASURES WILL BE ASSESS WITH URTICARIA ACTIVITY SCORE AT EVERY MONTH UPTO 8 MONTH PARTICIPANTS FOLLOW UP AT EVERY MONTH AND AS PER NEED OF CASE FOR 8 MONTHS OF DURATION |